Insider Sell: Andrew Callos Sells Shares of Cytokinetics Inc (CYTK)

Andrew Callos, Executive Vice President and Chief Commercial Officer at Cytokinetics Inc (CYTK), sold 3,639 shares of the company on March 31, 2026. This transaction brings his total ownership to 66,004 shares. The article notes a history of insider selling at Cytokinetics Inc with no insider buys in the past year, and suggests the stock may be a “Possible Value Trap” based on its GuruFocus Value.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin